Valuation: Stereotaxis, Inc.

Market Cap 86.43M 77.41M 71.21M 64.52M 121M 8.21B 123M 849M 341M 4.32B 324M 317M 13.61B P/E 2026 *
-4.24x
P/E 2027 * -5.88x
Enterprise Value 86.43M 77.41M 71.21M 64.52M 121M 8.21B 123M 849M 341M 4.32B 324M 317M 13.61B EV / Sales 2026 *
2.52x
EV / Sales 2027 * 1.89x
Free-Float
84.79%
Yield 2026 *
-
Yield 2027 * -
1 day-5.21%
1 week-15.43%
1 month-29.87%
3 months-31.54%
6 months-53.87%
Current year-62.50%
1 week 0.81
Extreme 0.8101
1.04
1 month 0.81
Extreme 0.8101
1.22
Current year 0.81
Extreme 0.8101
2.86
1 year 0.81
Extreme 0.8101
2.93
3 years 0.81
Extreme 0.8101
3.59
5 years 0.81
Extreme 0.8101
7.22
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 03/02/2017
Director of Finance/CFO 57 01/10/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 01/02/2005
Chairman - 03/02/2017
Director/Board Member 71 29/09/2016
Date Insider Type Main position Quantity % Market Cap. Importance
1/7/26 Free

Director

43,103 0.0441%
1/7/26 Free

Director

43,103 0.0441%
1/7/26
DAFNA Capital Management LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-5.21%-15.43%-70.36%-42.87% 86.43M
-1.72%+3.44%+22.84%+56.71% 258B
-2.00%+0.75%+7.82%+20.94% 163B
-3.73%-4.48%-19.14%+64.75% 150B
-1.66%-8.12%-58.32%-17.99% 60.84B
-.--%+2.46%-11.69%-7.41% 53.31B
-2.57%+3.30%+11.59%+44.40% 53.03B
+0.84%-3.12%+7.47%+62.40% 50.67B
-3.47%+1.04%+19.48%+69.17% 49.3B
-3.61%+1.99%+32.36%+93.99% 45.46B
Average -2.31%-1.82%-5.79%+34.41% 88.41B
Weighted average by Cap. -2.10%+0.15%+4.02%+44.64%

Financials

2026 *2027 *
Net sales 34.33M 30.75M 28.28M 25.63M 47.9M 3.26B 48.8M 337M 135M 1.71B 129M 126M 5.41B 45.67M 40.9M 37.62M 34.09M 63.72M 4.34B 64.91M 449M 180M 2.28B 171M 168M 7.19B
Net income -20.13M -18.03M -16.59M -15.03M -28.09M -1.91B -28.62M -198M -79.4M -1.01B -75.56M -73.95M -3.17B -14.77M -13.23M -12.16M -11.02M -20.6M -1.4B -20.99M -145M -58.24M -738M -55.42M -54.24M -2.33B
Net Debt - -
Projected Income Statement - Annual - Stereotaxis, Inc.
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
30/10/26 USD 0.8626 -5.21% 1,440,946
29/10/26 USD 0.9100 -6.21% 812,862
28/10/26 USD 0.9703 -5.80% 309,539
27/10/26 USD 1.030 +4.04% 565,945
26/10/26 USD 0.9900 -2.94% 328,787
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Stereotaxis, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.8626USD
Average target price
3.000USD
Spread / Average Target
+247.79%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Stereotaxis, Inc.
  1. Stock Market
  2. Stocks
  3. STXS Stock